Summary
We examined renal responses to a pharmacological dosage of human atrial natriuretic peptide (hANP) and the potential interference of nifedipine administration with the effects of hANP on kidney function in healthy subjects and normoglycemic patients with type 1 diabetes mellitus. Ten healthy volunteers (age, 28±1 years) and ten patients (age, 33±2 years; diabetes duration; 14±3 years; HbAI 7.2%±0.2%) were studied. According to a double-blind, randomized, placebo-controlled trial design, three experiments were performed in each subject using the doubledummy technique: placebo only, hANP only, and nifedipine+hANP. As i.v. bolus injection 100 µg hANP was given; nifedipine was applied buccally, at a dose of 10 mg 90 min before and at a dose of 5 mg together with hANP injection. At base-line and in the placebo only experiment, patients did not differ from controls. In the hANP only experiment, in both groups hANP resulted in increased urinary volume and both sodium and chloride excretion (P<0.05 vs placebo only experiment). In patients, hANP-induced increase in electrolyte excretion was greater than in controls (P<0.05). In the nifedipine + hANP experiment, hANP-induced changes in renal indexes were enhanced in controls (P<0.05 vs hANP only experiment) but not in patients. Thus, diuretic response to nifedipine + hANP in patients was decreased in comparison with controls (P<0.05). In patients, however, nifedipine administration decreased the hANP-induced increase in urinary albumin excretion (P<0.05 vs hANP only experiment). Creatinine clearance was uninfluenced throughout the experiments.
There were similar decreases in blood pressure in patients and controls after nifedipine administration (P<0.05 vs placebo only experiment). The increase in heart rate after nifedipine was more pronounced in patients than in controls (P<0.05). Conversely, plasma renin activity was stimulated by nifedipine only in controls (P<0.05 vs placebo only experiment). In this study hANP had no effect on heart rate, blood pressure, or plasma renin activity. There was a short-term increase in hANP levels in plasma after nifedipine administration in controls (P<0.05 vs placebo only experiment) but not in patients. In contrast to a previous study, where renal responses to the same pharmacological dosage of hANP were decreased in patients with type 1 diabetes mellitus with HbAI exceeding the normal range, there is no impairment of renal responsiveness to an i.v. bolus of hANP in patients with HbAI within the normal range. Nifedipine and hANP have synergistic effects on kidney function in healthy subjects. It remains to be studied, however, by which mechanism(s) this synergism could be obscured in diabetes patients. Moreover, the increase in hANP levels after nifedipine administration exclusively in controls merits further investigation.
Similar content being viewed by others
Abbreviations
- hANP:
-
Human atrial natriuretic peptide
- HbAI:
-
Glycosylated hemoglobin AI
- HbAI c:
-
Glycosylated haemoglobin AI c
References
Anderson S, Brenner BM (1988) Pathogenesis of diabetic glomerulopathy: hemodynamic considerations. Diabetes/Metab Rev 4:163–177
Brezis M, Epstein FH (1989) A closer look at radiocontrast-induced nephropathy. N Engl J Med 320:179–181
Camargo MJF, Kleinert HD, Atlas SA, Sealey JE, Laragh JH, Maack T (1984) Ca-dependent hemodynamic and natriuretic effects of atrial extract in isolated rat kidney. Am J Physiol 246:F447-F456
Crozier IG, Nicholls MG, Ikram H, Espiner EA, Gomez HJ, Warner NJ (1986) Haemodynamic effects of atrial peptide infusions in heart failure. Lancet II:1242–1245
Cuneo RC, Espiner EA, Nicholls MG, Yandle TG, Joyce SL, Gilchrist NL (1986) Renal, hemodynamic, and hormonal responses to atrial natriuretic peptide infusions in normal men, and effect of sodium intake. J Clin Endocrinol Metab 63:946–953
De Chätel R, Tóth M, Barna I (1986) Exchangeable body sodium: its relationship with blood pressure and atrial natriuretic factor in patients with diabetes mellitus. J Hypertension 4 [Suppl 6]:S526-S528
Ditzel J, Brøchner-Mortensen J, Rødbro P (1981) Elevated glomerular filtration rate in early diabetes may be explained by increased sodium reabsorption secondary to an impairment in renal tubular handling of phosphate. Horm Metab Res [Suppl Series] 11:87–89
Espiner EA, Richards AM (1989) Atrial natriuretic peptide. Lancet I:707–710
Feldt-Rasmussen B, Mathiesen ER, Deckert T, Giese J, Christensen NJ, Bent-Hansen L, Nielsen MD (1987) Central role for sodium in the pathogeneis of blood pressure changes independent of angiotensin, aldosterone and catecholamines in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 30:610–617
Gardner DG, LaPointe MC, Wu J, Baxter JD, Gertz BJ (1989) Hormonal regulation of the gene for atrial natriuretic factor. In: Brenner BM, Laragh JH (eds) Advances in atrial peptide research, Vol. 2. Raven Press, New York
Jungmann E, Wirth K, Rosak C, Althoff PH (1986) Erhöhte endogene Dopaminaktivität beim Diabetes mellitus. Fortschr Med 104:869–870
Jungmann E, Konzok C, Höll E, Fassbinder W, Schöffling K (1989) The effect of human atrial natriuretic peptide on renal and cardiovascular responses to insulin-induced hypoglycemia in healthy man. In: Forssmann WG, Scheuerman DW, Alt J (eds) Functional morphology of the endocrine heart. Steinkopff Verlag, Darmstadt, pp 235–239
Jungmann E, Walter-Schräder MC, Haak T, Fassbinder W, Wambach G, Althoff PH, Schöffling K (1988) Impaired renal responsiveness to human atrial natriuretic peptide (hANP) in normotensive patients with type 1 diabetes mellitus. Klin Wochenschr 66:527–532
Jungmann E, Schirmer U, Scheuermann EH, Zeuzem S, Schöffling K (in press) Renal action of human atrial natriuretic peptide in active acromegaly. In: Brenner BM, Laragh JH (eds) Advances in atrial peptide research. Vol 3. Raven Press, New York
Krusell LR, Christensen CK, Lederballe Pedersen O (1987) Acute natriuretic effects of nifedipine in hypertensive patients and normotensive controls — a proximal tubular effect? Eur J Clin Pharmacol 32:121–126
Lederballe Pedersen O, Mikkelsen E, Christensen NJ, Kornerup HJ, Pedersen EB (1979) Effect of nifedipine on plasma renin, aldosterone and catecholamines in arterial hypertension. Eur J Clin Pharmacol 15:235–240
McMurray J, Struthers AD (1988) Frusemide pretreatment blunts the inhibition of renal tubular sodium reabsorption by ANF in man. Eur J Clin Pharmacol 35:333–338
McMurray J, Seidelin PH, Howey J, Struthers AD (1989) Atrial natriuretic factor increases urinary albumin excretion in man. In: Brenner BM, Laragh JH (eds) Advances in atrial peptide research, vol 3. Raven Press, New York
Nakaoka H, Kitahara Y, Amano M, Imataka K, Fujii J, Miyuki I, Yamaji T (1987) Effect of β-adrenergic receptor blockade on atrial natriuretic peptide in essential hypertension. Hypertension 10:221–225
O'Hare JA, Ferriss JB, Brady D, Twomey B, O'Sullivan D (1985) Exchangeable sodium and renin in hypertensive diabetic patients with and without nephropathy. Hypertension 7 [Suppl II]:II-43–II-48
O'Hare JP, Corrall RJM (1988) De natrio diabeticorum. Diab Med 5:22–26
Parfrey PS, Griffiths SM, Barrett BJ, Paul MD, Genge M, Withers J, Farid N, McManamon PJ (1989) Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. N Engl J Med 320:143–149
Predelk HG, Schulte-Vels O, Sorger M, Glänzer K, Kramer HJ (1989) Effects of alpha-hANP on renal and systemic hemodynamics in patients with diabetes mellitus. In: Brenner BM, Laragh JH (eds) Advances in atrial peptide research, vol 3. Raven Press, New York
Riegger AJG, Kromer EP, Kochsiek K (1986) Atrial natriuretic peptide in patients with severe heart failure. Klin Wochenschr 64 [Suppl VI]:89–92
Sachs L (1978) Angewandte Statistik. Springer-Verlag, Berlin Heidelberg New York
Schafferhans K, Strohmeier J, Geiger H, Bahner U, Landwehr EP, Heidland A (in press) Contrast media induced acute renal failure-protective action of atrial natriuretic peptide. Klin Wochenschr [Suppl]
Schafferhans K, Heidbreder E, Nöthen M, Stöckl P, Heidland A (in press) Reversal of cyclosporin-induced acute renal failure by the atrial natriuretic peptide. Klin Wochenschr [Suppl]
Schnermann J, Briggs JP (1988) The physiological importance of atrial natriuretic peptide. In: Forssmann WG, Scheuermann DW, Alt J (eds) Functional morphology of the endocrine heart. Springer Verlag, New York
Seino M, Abe K, Nushiro N, Yoshinaga K (1988) Nifedipine enhances the vasodepressor and natriuretic effects of atrial natriuretic peptide. Hypertension 11:34–40
Trevisan R, Fioretto P, Giorato C, Semplicini A, Velussi M, Donadron V, Tiengo A, Monesi G, Mollo G, Crepaldi C, Nosadini R (1988) An impaired natriuretic response to isotonic volume expansion characterises normotensive and hypertensive type 1 (insulin-dependent) diabetic patients with normal albumin excretion rate in comparison with normotensive and hypertensive non-diabetic subjects. Diabetologia 31:551A
Vierhapper H, Bratusch-Marrain P, Ratheiser K, Waldhäusl W (in press) The diuretic and natriuretic action of human atrial natriuretic peptide in man — lack of effect of exogenous insulin. Metabolism
Weidmann P, Beretta-Piccoli C, Keusch G, Cluck Z, Mujagiz M, Grimm M, Meier A, Ziegler AH (1979) Sodium-volume factor, cardiovascular reactivity and hypertension of diabetes mellitus. Am J Med 67:779–784
Weidmann P, Saxenhofer H, Ferrier C, Shaw SG (1989) Atrial natriuretic peptide in man. In: Forssmann WG, Scheuermann DW, Alt J (eds) Functional morphology of the endocrine heart. Springer Verlag, New York
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jungmann, E., Seel, K., Hofmann, E. et al. Effects of nifedipine on renal responses to human atrial natriuretic peptide in healthy subjects and normoglycemic patients with type 1 diabetes mellitus. Klin Wochenschr 67, 1174–1181 (1989). https://doi.org/10.1007/BF01716204
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01716204